InterDigital Inc (IDCC)

[sonetirot]

Unrelated to IDCC However I wish one day we woke up with new like this. Share price already bid up $65 Bid / $77 Ask in early trade (before market)

Biotechnology company Celgene Corp. agreed to acquire Pharmion Corp., a maker of blood-cancer treatments, for $2.9 billion in cash and stock as part of its drive to become a major global player in developing and marketing blood-cancer drugs.

Celgene, of Summit, N.J., said it agreed to pay Pharmion shareholders $72 a share, a nearly 50% premium over the stock's closing share price on Friday, and nearly three times the level where Pharmion shares started in 2007.

Pharmion shareholders will receive about one-third cash and the rest in Celgene stock, at a ratio that will be determined later. The boards of both companies have approved the deal but it still requires shareholder and regulatory approval.

Pharmion's shares jumped about 5% Friday and an additional 2% in after-hours trading, suggesting that word of the deal may have leaked. They rose Friday to $49.28 in 4 p.m. Nasdaq Stock Market composite trading.

http://online.wsj.com/article/SB119542866365497341.html?mod=yahoo_hs&ru=yahoo